Showing 1,201 - 1,220 results of 18,449 for search 'significantly ((((((step decrease) OR (we decrease))) OR (a decrease))) OR (observed decrease))', query time: 0.81s Refine Results
  1. 1201
  2. 1202
  3. 1203
  4. 1204

    Schematic diagram of soil sample collection. by Xianyong Wang (22601067)

    Published 2025
    “…Soil organic carbon and organic matter levels tended to increase on day 5 post-fertilization but generally decreased by day 10, with more pronounced declines observed in low-rate treatments (e.g., 1F). …”
  5. 1205
  6. 1206
  7. 1207
  8. 1208

    Raw metabolomic data. by Bhuripit Saraphol (20855573)

    Published 2025
    “…The fecal metabolomic analysis showed that key signaling pathways, including the mechanistic target of rapamycin (mTOR), phosphatidylinositol 3-kinase (PI3K)-Akt, and AMP-activated protein kinase (AMPK) pathways, were enriched in thin cows. In addition, a significant correlation was observed between differential microbial taxa and metabolites. …”
  9. 1209

    Schematic diagram of the experimental workflow. by Bhuripit Saraphol (20855573)

    Published 2025
    “…The fecal metabolomic analysis showed that key signaling pathways, including the mechanistic target of rapamycin (mTOR), phosphatidylinositol 3-kinase (PI3K)-Akt, and AMP-activated protein kinase (AMPK) pathways, were enriched in thin cows. In addition, a significant correlation was observed between differential microbial taxa and metabolites. …”
  10. 1210

    Characteristics of the included studies. by Xin Liu (43569)

    Published 2025
    “…The combined findings showed that high-dose TXA was associated with a significant reduction in intraoperative blood loss [weighted mean difference (WMD) =  -215.48, 95% confidence interval (CI) (-367.58, -63.37), P <  0.001], as well as a decreased likelihood of transfusion [risk ratio (RR) =  0.40, 95% CI (0.30, 0.53), P <  0.001]. …”
  11. 1211

    Summary of results. by Xin Liu (43569)

    Published 2025
    “…The combined findings showed that high-dose TXA was associated with a significant reduction in intraoperative blood loss [weighted mean difference (WMD) =  -215.48, 95% confidence interval (CI) (-367.58, -63.37), P <  0.001], as well as a decreased likelihood of transfusion [risk ratio (RR) =  0.40, 95% CI (0.30, 0.53), P <  0.001]. …”
  12. 1212

    Bias risk assessments for each RCT study. by Xin Liu (43569)

    Published 2025
    “…The combined findings showed that high-dose TXA was associated with a significant reduction in intraoperative blood loss [weighted mean difference (WMD) =  -215.48, 95% confidence interval (CI) (-367.58, -63.37), P <  0.001], as well as a decreased likelihood of transfusion [risk ratio (RR) =  0.40, 95% CI (0.30, 0.53), P <  0.001]. …”
  13. 1213

    The flow chart of studies selecting. by Xin Liu (43569)

    Published 2025
    “…The combined findings showed that high-dose TXA was associated with a significant reduction in intraoperative blood loss [weighted mean difference (WMD) =  -215.48, 95% confidence interval (CI) (-367.58, -63.37), P <  0.001], as well as a decreased likelihood of transfusion [risk ratio (RR) =  0.40, 95% CI (0.30, 0.53), P <  0.001]. …”
  14. 1214

    Funnel plots for intraoperative blood loss. by Xin Liu (43569)

    Published 2025
    “…The combined findings showed that high-dose TXA was associated with a significant reduction in intraoperative blood loss [weighted mean difference (WMD) =  -215.48, 95% confidence interval (CI) (-367.58, -63.37), P <  0.001], as well as a decreased likelihood of transfusion [risk ratio (RR) =  0.40, 95% CI (0.30, 0.53), P <  0.001]. …”
  15. 1215

    Bias risk assessments for each RCS study. by Xin Liu (43569)

    Published 2025
    “…The combined findings showed that high-dose TXA was associated with a significant reduction in intraoperative blood loss [weighted mean difference (WMD) =  -215.48, 95% confidence interval (CI) (-367.58, -63.37), P <  0.001], as well as a decreased likelihood of transfusion [risk ratio (RR) =  0.40, 95% CI (0.30, 0.53), P <  0.001]. …”
  16. 1216

    Overview of selected datasets. by Tejaswini Baral (14320736)

    Published 2025
    “…In this study, we analyzed publicly available 16S amplicon sequencing datasets from four geographical locations using a single workflow.…”
  17. 1217
  18. 1218

    Table 1 - by Marco Carbonara (11483575)

    Published 2024
    Subjects:
  19. 1219

    Patient status overview. by Farayi Kaseke (19560197)

    Published 2024
    “…<div><p>Background</p><p>In this longitudinal study, we aimed to determine factors influencing survival outcomes among patients with stroke at three tertiary hospitals over a 12-month period. …”
  20. 1220